drugset / Trial / NCT02669199

MSCs Source of Sweat Gland Cells of Large Area Skin Injury Patients Transplant of the Wound

NCT02669199 ↗

Phase 1 Completed 20 enrolled Chinese PLA General Hospital
NaSingle-groupOpen-labelTreatment

Summary

The main purpose of this test is to assess the umbilical cord mesenchymal stem cells (MSCs) UC between source sample sweat gland cells wound transplanted effectiveness and safety for the treatment of large area skin lesions of the subjects

Timeline

Start
2012-01
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject MSCs Cell therapy — —

Indications

No indication recorded.